Researchers from the Indiana University School of Medicine hope to develop new glaucoma therapies by testing human neurons and a regenerative therapy to rescue

Positive top-line results have been announced from a confirmatory clinical study for AVT06, a biosimilar to Eylea (aflibercept) developed by the biotech Alvotech.

Adopting the ‘365 breathing technique’ helped reduce intraocular pressure (IOP) in primary openangle glaucoma patients, a new study has found.

Autonomous artificial intelligence (AI) systems for diagnosing diabetic eye disease (DED) have the potential to increase DED screening rates in underserved youth, while also